A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors

NCT03980509 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Curcumin

Sponsor

Medical University of South Carolina